Revenue Update on Cynosure(NASDAQ:CYNO)

Cynosure(NASDAQ:CYNO) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Jul 26, 2016. Company reported revenue of $110.34M. Analysts estimated a revenue of $101.31M. Earnings per share were $0.36. Analysts had estimated an EPS of $0.29.

Cynosure (CYNO) made into the market gainers list on Fridays trading session with the shares advancing 2.10% or 1.13 points. Due to strong positive momentum, the stock ended at $54.96, which is also near the day’s high of $55.08. The stock began the session at $53.69 and the volume stood at 2,59,245 shares. The 52-week high of the shares is $55.94 and the 52 week low is $29. The company has a current market capitalization of $1,293 M and it has 2,35,22,695 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On May 16, 2016, Douglas J Delaney (Executive VP, Sales) sold 12,299 shares at $46.49 per share price.Also, On May 16, 2016, Michael R Davin (Chairman and CEO) sold 26,271 shares at $46.49 per share price.On Apr 19, 2016, Timothy W Baker (President and CFO) sold 14,008 shares at $45.02 per share price, according to the Form-4 filing with the securities and exchange commission.

Cynosure Inc. develops and markets aesthetic treatment systems that enable plastic surgeons dermatologists and other medical practitioners to perform procedures to remove hair treat vascular and benign pigmented lesions remove multi-colored tattoos revitalize the skin liquefy and remove unwanted fat through laser lipolysis reduce cellulite clear nails infected by toe fungus ablate sweat glands and improve vaginal health. The Company also markets radiofrequency (RF) energy sourced medical devices for precision surgical applications such as facial plastic and general surgery; gynecology; ear nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry and proctology. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Cynosure - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cynosure. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.